UPDATE: Oppenheimer Initiates Coverage on Rockwell Medical with Outperform Rating, $24 PT on Significant Expected Upside - Rockwell Medical (NASDAQ:RMTI)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

In a report published Wednesday, Oppenheimer analyst Ling Wang initiated coverage on

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Rockwell Medical

(NASDAQ: RMTI) with an Outperform rating and $24.00 price target.In the report, Oppenheimer noted, “We are initiating coverage on RMTI with an Outperform rating and price target of $24. We expect RMTI shares to have significant upside to be driven by the potential regulatory approval of Triferic™ as iron replacement therapy for chronic kidney disease (CKD) patients on hemodialysis in 1Q15, possible market launch of both Triferic™ and Calcitriol in 1H15 and significant top and bottom line growth (we project RMTI reaching profitability in 2015 assuming Triferic™ approval).”Rockwell Medical closed on Tuesday at $9.51.